Concepedia

Angelo L. Grauel

AL

Statistics

Publications

5

Citations

615

H-Index

5

Active since

2018

Affiliations

Novartis (China)(Current)

Novartis (Switzerland)

Harvard University

Novartis (United States)

Angelo L. Grauel is an author at Novartis (China) specializing in tumor microenvironment, medicine, and oncology.

ORCID

Publications per year

2018–2023

5

Publications

5

FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

Viviana Cremasco, Jillian L. Astarita, Angelo L. Grauel et al. · Cancer Immunology Research · 2018 · 203 citations · Full text

, , +17

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts

Angelo L. Grauel, Beverly Nguyen, David A. Ruddy et al. · Nature Communications · 2020 · 203 citations · Full text

, , +17

Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing

Guadalupe J. Jasso, Alok Jaiswal, Mukund Varma et al. · PLoS Biology · 2022 · 102 citations · Full text

, , +17

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms

Ye Wang, Morvarid Mohseni, Angelo L. Grauel et al. · Scientific Reports · 2021 · 73 citations · Full text

, , +17

Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses

Rohan Diwanji, Neil A. O’Brien, Jiyoung E. Choi et al. · Cancer Immunology Research · 2023 · 34 citations

, , +17

1–5 of 5